Sections
Title | Starting Page | Number of Pages |
---|
Overview | 1 | 1 |
Business model | 1 | 1 |
Revenue momentum and operating leverage driving NPAT | 1 | 1 |
Base-case DCF valuation is $0.37/share (previously $0.31) | 1 | 1 |
Table/Chart: Historical earnings and RaaS’ forecasts (in $A unless otherwise stated) | 1 | 1 |
Graph: Share Performance (12 months) | 1 | 1 |
Upside Case | 1 | 1 |
Downside Case | 1 | 1 |
Catalysts | 1 | 1 |
Table/Chart: Board of Directors | 1 | 1 |
Table/Chart: Share Details | 1 | 1 |
Disclosure | 1 | 1 |
H1 FY25 Results Discussion | 2 | 1 |
Graph: Exhibit 1: Half-year revenue H1 FY19-H1 FY25 | 2 | 1 |
Table/Chart: Exhibit 2: H1 FY25 versus H1 FY24 and RaaS forecasts for H1 FY25 (in A $m unless otherwise stated) | 2 | 1 |
Earnings Adjustments | 2 | 1 |
Table/Chart: Exhibit 3: Earnings adjustments (in A $m unless otherwise stated) | 3 | 1 |
DCF Valuation Upgraded | 3 | 1 |
Table/Chart: Exhibit 4: DCF valuation | 3 | 1 |
Table/Chart: Exhibit 5: Financial Summary | 4 | 1 |
FINANCIAL SERVICES GUIDE | 5 | 1 |
RaaS Research Group Pty Ltd | 5 | 1 |
Corporate Authorised Representative, number 1248415, of | 5 | 1 |
About Us | 5 | 1 |
Our general advice service | 5 | 1 |
How are we paid? | 5 | 1 |
Associations and Relationships | 5 | 1 |
Complaints | 5 | 1 |
Professional Indemnity Insurance | 5 | 1 |
Disclosure | 6 | 1 |